Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saliva pharmacokinetics of immediate-release versus sustained-release methylphenidate in children with ADHD
NL-OMON37735Phase 4Withdrawn
- Sponsor
- Maasstad Ziekenhuis
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Maasstad Ziekenhuis. Primary endpoint: Area under the methylphenidate saliva concentration-time curve. Planned start Feb 2013; status: withdrawn.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON37735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37735.